Similar findings of increased oxidative stress susceptibility with PON2 deficiency have been reported in numerous disease models, including atherosclerosis [16,22], heart failure [68], impaired hepatic insulin signaling [69], and obesity [47]. This evidence concerns the gene PON2 and obesity due to melanocortin 4 receptor deficiency.